Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The research laboratory led by Sumera I. Ilyas, M.B.B.S., is focused on the immunobiology of liver cancer. Because of the limited understanding of the immune microenvironment of liver cancer, there is ample opportunity for Dr. Ilyas' lab to contribute to a deeper comprehension of disease pathogenesis and advancements in treatment. Her research team employs immunocompetent models of primary and metastatic liver cancer to study mechanisms of tumor immune evasion. The long-term goal of Dr. Ilyas' research is to develop immune-directed therapies for the treatment of cancer.
Dr. Ilyas' career goal is to improve the lives of patients with cancer. As a clinician-scientist, Dr. Ilyas is uniquely able to translate investigational observations into clinical practice. A better understanding of the immune microenvironment of liver cancer will guide development of novel immunotherapy combinations for the treatment of cancer.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.